CTTH (CTT Pharmaceutical Holdings) Cyclically Adjusted PB Ratio: (As of Aug. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is CTT Pharmaceutical Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CTT Pharmaceutical Holdings  (OTCPK:CTTH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CTT Pharmaceutical Holdings Cyclically Adjusted PB Ratio Related Terms


CTT Pharmaceutical Holdings Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for CTT Pharmaceutical Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CTT Pharmaceutical Holdings Cyclically Adjusted PB Ratio Chart

CTT Pharmaceutical Holdings Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.65 0.03 0.10 0.11

CTT Pharmaceutical Holdings Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Mar17 Jun17 Mar18 Jun18 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.09 0.11 0.11 0.00

CTTH vs AKAN, SBFM, PRFX: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, CTT Pharmaceutical Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTT Pharmaceutical Holdings Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CTT Pharmaceutical Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CTT Pharmaceutical Holdings's Cyclically Adjusted PB Ratio falls into.



CTT Pharmaceutical Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CTT Pharmaceutical Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, CTT Pharmaceutical Holdings's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/333.9520*333.9520
=0.000

Current CPI (Jun. 2026) = 333.9520.

CTT Pharmaceutical Holdings Quarterly Data

Book Value per Share CPI Adj_Book
200912 -1.531 215.949 -2.368
201003 0.621 217.631 0.953
201006 0.749 217.965 1.148
201009 0.154 218.439 0.235
201012 -0.358 219.179 -0.545
201103 6.042 223.467 9.029
201106 5.003 225.722 7.402
201109 4.530 226.889 6.668
201112 0.490 225.672 0.725
201203 0.816 229.392 1.188
201206 0.061 229.478 0.089
201209 -0.245 231.407 -0.354
201212 -0.410 229.601 -0.596
201303 -0.451 232.773 -0.647
201306 -0.506 233.504 -0.724
201309 -0.521 234.149 -0.743
201312 -0.031 233.049 -0.044
201403 -0.279 236.293 -0.394
201406 0.024 238.343 0.034
201409 0.000 238.031 0.000
201412 0.077 234.812 0.110
201503 0.015 236.119 0.021
201506 0.046 238.638 0.064
201509 0.035 237.945 0.049
201512 0.016 236.525 0.023
201603 0.003 238.132 0.004
201606 -0.009 241.018 -0.012
201609 -0.015 241.428 -0.021
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201803 -0.006 249.554 -0.008
201806 0.016 251.989 0.021
202409 0.000 315.301 0.000
202412 0.001 315.605 0.001
202503 0.000 319.799 0.000
202506 0.001 322.561 0.001
202509 0.001 324.800 0.001
202512 0.001 324.054 0.001
202603 0.001 330.213 0.001
202606 0.000 333.952 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CTT Pharmaceutical Holdings Business Description

Address 3853 Northdale Boulevard, Suite 268, Tampa, FL, USA, 33624
CTT Pharmaceutical Holdings Inc specializes in drug delivery systems technology within the pharmaceutical industry. Its focus is on fast-dissolving drug delivery systems through the development of oral delivery thin wafers. The company's technology platform includes the development of oral delivery thin wafers to deliver treatment as an alternative to smoking and ingestion. This technology platform target both the human and veterinarian(pet) markets for treatment of many diseases. The Company believes that its technology will be one of the first to gain use in majorly markets such as pain management and smoking cessation. The Oral Thin Film formulation is protected by patents in the USA, Canada, Europe and many other countries across the world.